This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips, S.
Right arrow Articles by Parekh, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, S.
Right arrow Articles by Parekh, B. S.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 2000, p. 698-699, Vol. 7, No. 4
1071-412X/00/$04.00+0

Diagnosis of Human Immunodeficiency Virus Type 1 Infection with Different Subtypes Using Rapid Tests

Susan Phillips,1 Timothy C. Granade,1 Chou-Pong Pau,1 Debra Candal,1 Dale J. Hu,2 and Bharat S. Parekh1,*

HIV Immunology and Diagnostics Branch1 and International Activity Branch,2 Centers for Disease Control and Prevention, Atlanta, Georgia 30333

Received 6 January 2000/Returned for modification 22 March 2000/Accepted 3 April 2000

We evaluated six rapid tests for their sensitivity and specificity in diagnosing human immunodeficiency virus type 1 (HIV-1) infection using 241 specimens (172 HIV-1 positive, 69 HIV-1 negative) representing different HIV-1 subtypes (A [n = 40], B [n = 47], C [n = 28], E [n = 42], and F [n = 7]). HIVCHEK, Multispot, RTD and SeroStrip were 100% sensitive and specific. Capillus failed to identify two of eight subtype C specimens (overall sensitivity of 98.85%), while the SUDS test (the only test approved by the Food and Drug Administration) gave false-positive results for 5 of 69 seronegative specimens (specificity of 93.24%). Our results suggest that although rapid tests perform well in general, it may be prudent to evaluate a rapid test for sensitivity and specificity in a local population prior to its widespread use.


* Corresponding author. Mailing address: Centers for Disease Control and Prevention, HIV Immunology and Diagnostics Branch, Mailstop D12, 1600 Clifton Rd., Atlanta, GA 30333. Phone: (404) 639-3647. Fax: (404) 639-2660. E-mail: bsp1{at}cdc.gov.


Clinical and Diagnostic Laboratory Immunology, July 2000, p. 698-699, Vol. 7, No. 4
1071-412X/00/$04.00+0



This article has been cited by other articles:

  • Vijayakumar, T.-S., David, S., Selvaraj, K., Viswanathan, T., Kannangai, R., Sridharan, G. (2005). Performance of a Rapid Immunochromatographic Screening Test for Detection of Antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2: Experience at a Tertiary Care Hospital in South India. J. Clin. Microbiol. 43: 4194-4196 [Abstract] [Full Text]  
  • Gupta, A., Chaudhary, V. K. (2003). Whole-Blood Agglutination Assay for On-Site Detection of Human Immunodeficiency Virus Infection. J. Clin. Microbiol. 41: 2814-2821 [Abstract] [Full Text]  
  • Ramalingam, S., Kannangai, R., Raj A, A., Jesudason, M. V., Sridharan, G. (2002). Rapid Particle Agglutination Test for Human Immunodeficiency Virus: Hospital-Based Evaluation. J. Clin. Microbiol. 40: 1553-1554 [Abstract] [Full Text]  
  • Martin, C. A., Keren, D. F. (2002). Comparison of Murex Single-Use Diagnostic System with Traditional Enzyme Immunoassay for Detection of Exposure to Human Immunodeficiency Virus. CVI 9: 187-189 [Abstract] [Full Text]  
  • Koch, W. H., Sullivan, P. S., Roberts, C., Francis, K., Downing, R., Mastro, T. D., Nkengasong, J., Hu, D., Masciotra, S., Schable, C., Lal, R. B. (2001). Evaluation of United States-Licensed Human Immunodeficiency Virus Immunoassays for Detection of Group M Viral Variants. J. Clin. Microbiol. 39: 1017-1020 [Abstract] [Full Text]